Is ophthalmologic screening essential during alpha interferon treatment? [1];Faut-il imposer une surveillance ophtalmologique chez les patients sous interféron alpha? [1]

Annales de Dermatologie et de Venereologie

Volumn 128, Issue 3 I, 2001, Pages 257-

  Emonet Mercier, E ^a,b   Touraud, J P ^a,b   Tsan, P ^a,b   Chapard, J ^a,b   Dalac, S ^a,b   Lambert, D ^a,b  

^a HÔPITAL DU BOCAGE   (France)

^b DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; RECOMBINANT ALPHA2A INTERFERON;

ALOPECIA; AUTOIMMUNE DISEASE; CARDIOMYOPATHY; DEPRESSION; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DOSE RESPONSE; HEPATITIS C; HUMAN; IMMUNOTHERAPY; INFLUENZA; LETTER; MELANOMA; OPHTHALMOSCOPY; PATIENT MONITORING; RETINA BLOOD FLOW; RETINOPATHY;

AGED; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; INTERFERON-ALPHA; RETINAL VEIN OCCLUSION;

EID: 0035044699     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Rétinopathie sous interféron alpha au cours d'un traitement pour mélanome
2. Retinal complications during interferon therapy for chronic hepatitis
3. Interferon associated retinopathy
4. Outlook for the future in the treatment of diabetic retinopathy
5. Ocular complications with high dose interferon alpha in chronic active hepatitis
6. Retinopathy and subconjunctival haemorrhage in patients with chronic viral hepatitis receiving interferon alpha